Omega Fund Management, LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001637359 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Nov 15, 2021

Total Value: $884M

Holdings (23)

NUVB Nuvation Bio 29.7%

Value $263M Shares 28,212,376 Est. Cost $11.18 Unrealized +2.0%

REPL Replimune Group 21.8%

Value $192M Shares 5,008,245 Est. Cost $17.40 Unrealized +96.5%

— Morphic Holding 11.5%

Value $101M Shares 1,767,350 Est. Cost $19.82 Unrealized —

— Kronos Bio 10.3%

Value $91.45M Shares 3,818,283 Est. Cost $29.87 Unrealized —

— Ikena Oncology 3.6%

Value $31.58M Shares 2,249,123 Est. Cost $28.25 Unrealized —

GOSS Gossamer Bio 3.1%

Value $26.96M Shares 3,320,608 Est. Cost $20.85 Unrealized -58.4%

— Spruce Biosciences 2.7%

Value $24.23M Shares 2,161,022 Est. Cost $24.31 Unrealized —

IMUX Immunic 2.5%

Value $21.92M Shares 1,788,160 Est. Cost $13.89 Unrealized -0.4%

— Paratek Pharmaceuticals 2.0%

Value $17.73M Shares 2,600,410 Est. Cost $34.18 Unrealized —

ARQT Arcutis Biothereapeutics 1.9%

Value $17.02M Shares 623,836 Est. Cost $26.87 Unrealized +4.8%

SANA Sana Biotechnology, Inc. 1.9%

Value $16.59M Shares 843,750 Est. Cost $32.56 Unrealized -30.4%

AVIR Atea Pharmaceuticals 1.8%

Value $16.04M Shares 746,868 Est. Cost $32.23 Unrealized -6.8%

— Syros Pharmaceuticals 1.4%

Value $12.4M Shares 2,274,831 Est. Cost $9.16 Unrealized —

— Alpine Immune Sciences 1.3%

Value $11.56M Shares 1,284,900 Est. Cost $8.79 Unrealized —

— ESSA Pharma 1.1%

Value $9.377M Shares 328,196 Est. Cost $3.14 Unrealized —

— Checkmate Pharmaceuticals 0.9%

Value $7.957M Shares 1,335,050 Est. Cost $11.51 Unrealized —

— Omega Alpha SPAC 0.6%

Value $4.985M Shares 501,000 Est. Cost $9.98 Unrealized —

— Cidara Therapeutics 0.5%

Value $4.051M Shares 2,005,249 Est. Cost $5.64 Unrealized —

— FibroGen 0.4%

Value $3.479M Shares 130,646 Est. Cost $27.34 Unrealized —

— ObsEva 0.3%

Value $3.028M Shares 999,364 Est. Cost $9.76 Unrealized —

TRVI Trevi Therapeutics 0.3%

Value $2.843M Shares 1,263,408 Est. Cost $8.20 Unrealized -72.5%

IMCR Immunocore Holdings 0.2%

Value $2.012M Shares 51,535 Est. Cost $42.57 Unrealized —

— Jounce Therapeutics 0.2%

Value $1.873M Shares 275,513 Est. Cost $21.99 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
NUVB	Nuvation Bio	28,212,376	$263M	29.7%	$11.18	+2.0%	—	67080N101
REPL	Replimune Group	5,008,245	$192M	21.8%	$17.40	+96.5%	—	76029N106
—	Morphic Holding	1,767,350	$101M	11.5%	$19.82	—	—	61775R105
—	Kronos Bio	3,818,283	$91.45M	10.3%	$29.87	—	—	50107A104
—	Ikena Oncology	2,249,123	$31.58M	3.6%	$28.25	—	—	45175G108
GOSS	Gossamer Bio	3,320,608	$26.96M	3.1%	$20.85	-58.4%	—	38341P102
—	Spruce Biosciences	2,161,022	$24.23M	2.7%	$24.31	—	—	85209E109
IMUX	Immunic	1,788,160	$21.92M	2.5%	$13.89	-0.4%	—	4525EP101
—	Paratek Pharmaceuticals	2,600,410	$17.73M	2.0%	$34.18	—	—	699374302
ARQT	Arcutis Biothereapeutics	623,836	$17.02M	1.9%	$26.87	+4.8%	—	03969K108
SANA	Sana Biotechnology, Inc.	843,750	$16.59M	1.9%	$32.56	-30.4%	—	799566104
AVIR	Atea Pharmaceuticals	746,868	$16.04M	1.8%	$32.23	-6.8%	—	04683R106
—	Syros Pharmaceuticals	2,274,831	$12.4M	1.4%	$9.16	—	—	87184Q107
—	Alpine Immune Sciences	1,284,900	$11.56M	1.3%	$8.79	—	—	02083G100
—	ESSA Pharma	328,196	$9.377M	1.1%	$3.14	—	—	29668H708
—	Checkmate Pharmaceuticals	1,335,050	$7.957M	0.9%	$11.51	—	—	162818108
—	Omega Alpha SPAC	501,000	$4.985M	0.6%	$9.98	—	—	G6749V107
—	Cidara Therapeutics	2,005,249	$4.051M	0.5%	$5.64	—	—	171757107
—	FibroGen	130,646	$3.479M	0.4%	$27.34	—	—	31572Q808
—	ObsEva	999,364	$3.028M	0.3%	$9.76	—	—	H5861P103
TRVI	Trevi Therapeutics	1,263,408	$2.843M	0.3%	$8.20	-72.5%	—	89532M101
IMCR	Immunocore Holdings	51,535	$2.012M	0.2%	$42.57	—	—	45258D105
—	Jounce Therapeutics	275,513	$1.873M	0.2%	$21.99	—	—	481116101